News

Salesforce, Inc. CRM is set to release its second-quarter fiscal 2026 earnings on Sept. 3, and the spotlight is on how well its AI and cloud bets are paying off. Businesses are still investing in

Palo Alto Networks PANW ended the fourth quarter of fiscal 2025, showing strong growth in its Next-Generation Security (NGS) business. The company’s NGS annual recurring revenue (ARR) grew 32% year

NVIDIA Corporation NVDA recently reported yet another stellar quarterly performance, reinforcing its dominance in the artificial intelligence (AI) and semiconductor markets. On Aug. 27, the company

Simon Property Group SPG owns a diversified portfolio of premium retail assets in some of the key markets across the United States and globally. Solid retail real estate demand in the upcoming

Post Holdings, Inc. (POST) has agreed to divest the pasta business of its recently acquired 8th Avenue Food & Provisions to Richardson (US) Holdings Limited. Valued at $375 million in cash, with

Biogen BIIB announced that the FDA has approved a subcutaneous (SC) autoinjector version of Leqembi as a weekly maintenance dosing option for the treatment of early Alzheimer’s disease (AD). This

MGIC Investment Corporation MTG hit a 52-week high of $28.67 on Aug. 29. Shares closed at $27.83 after gaining 17.4% year to date, outperforming the industry, the sector, and the Zacks S&P 500

Walmart Inc.’s WMT second-quarter fiscal 2026 results underscore the company’s strong sales momentum. Revenues rose 5.6% in constant currency, fueled by e-commerce growth and solid performance in

Charles River Laboratories International, Inc. CRL is now part of the EASYGEN (Easy Workflow Integration for Gene Therapy) Consortium — a European Union-backed effort designed to produce CAR-T cell

Bio-Rad Laboratories, Inc. BIO is well-poised to grow in the upcoming quarters, courtesy of its strong traction in the QX600 Droplet Digital PCR (ddPCR) platform. Demand for its quality control and

Illinois Tool Works Inc. ITW is witnessing solid momentum in the Specialty Products segment. The segment is being driven by strength in the ground support equipment, consumer packaging and specialty

Kratos Defense & Security Solutions, Inc. KTOS is accelerating its progress in the defense industry through robust investments and partnerships in advanced propulsion programs. As nations across the

Ciena Corporation (CIEN) is scheduled to report third-quarter fiscal 2025 results on Sept. 4, before market open.

The Zacks Consensus Estimate for earnings is pegged at 52 cents per share, implying

Parker-Hannifin Corporation PH is witnessing strong momentum in the Aerospace Systems segment. The segment is benefiting from strong momentum in commercial and military end markets across both OEM

Wall Street expects a year-over-year increase in earnings on higher revenues when Oracle (ORCL) reports results for the quarter ended August 2025. While this widely-known consensus outlook is

Qualcomm Incorporated QCOM shares have plunged 8.3% over the past year against the industry’s growth of 36.2%. It has underperformed peers like Hewlett Packard Enterprise Company HPE and Broadcom

Dutch Bros Inc. (BROS) is pressing the accelerator on expansion, but the key question remains whether transaction growth can keep pace with its ambitious store rollout.

In the second quarter of

Shares of Hillman Solutions Corp. (HLMN) have gained 27.5% over the past four weeks to close the last trading session at $9.88, but there could still be a solid upside left in the stock if

El Pollo Loco Holdings (LOCO) closed the last trading session at $10.63, gaining 1.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Shares of The Pennant Group, Inc. (PNTG) have gained 8.8% over the past four weeks to close the last trading session at $24.01, but there could still be a solid upside left in the stock if

Shares of Natural Gas Services (NGS) have gained 12.3% over the past four weeks to close the last trading session at $26.16, but there could still be a solid upside left in the stock if short-term

Passage Bio, Inc. (PASG) closed the last trading session at $7.13, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by